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hronic chlamydial infections have been docu-
mented in numerous works 1,z as silently
evolving diseases. Evidence of resistance to antibi-
otic therapy, as demonstrated by positive cultures
long after treatment in infertile women,3,4 as well
as positive chlamydial antigens or nucleic acids in
culture-negative pelvic samples of infertile
womens and the discovery of chlamydial RNA and
inflammatory cytokines transcripts in tubes6 or
joints, 7 have led investigators to consider persis-
tence of the infectious material responsible for the
acquisition of chronicity. So far, animal models in
numerous works have proved the persistence of
viable chlamydiae in altered cell cultures. Many
authors have also associated serious sequelae of un-
suspected silent infections with the genetically re-
stricted host response to the heat shock proteins
(Hsps) secreted by bacteria, especially Hsp60 and
HspT0, which correspond to the chlamydial Gro-E1
and DNA-K genes,9-1z suggesting that repeated or
prolonged exposure to the Hsp antigens is respon-
sible for the strong host response against these bac-
terial Hsps and against self-Hsps homologous to
the bacterial ones. The consequence of the allo-
immunity to chlamydial antigens and Hsps, and of
the autoimmunity to self-Hsps, is persistent in-
flammation, scarring, fibrosis, and necrosis. The
clinical long-term female diseases documented are
ectopic pregnancy with altered ciliary tubal func-
tion, tubal infertility with obstructed tubes, and
early embryo rejection with immune interfer-
ence 14,1s in women undergoing in vitro fertilization
for tubal factor infertility. A normal chlamydial
growth can give viable chlamydiae recovered from
sick tissues of obstructed tubes without any previ-
ous notice of pelvic inflammatory disease (PID);
conversely, persistent chlamydiae can produce
overt infections. But, culture is almost impossible
unless multiple serial passages
16 are performed in
most chronic cases. It is not known whether
chronic chlamydial disease is a consequence of an
evolving silent (asymptomatic) infection, a natural
infection, or a thoroughly treated and eradicated
infection.
The clinical assumption of persistent chlamydial
infection in the genital tract has been reached by
the observation of functional disease associated
with a previous infection, documented by positive
chlamydial antibodies. The infectious etiology of
tubal obstruction has been assessed by several au-
thors, most often by chlamydial antibody testing, a7
However, it has never been clear whether anti-
chlamydial immunoglobulin (Ig) G is only a sero-
logic scar in the absence of specific IgA or IgM, nor
whether untreated cervical chlamydial infection
would ascend to the upper genital tract or self-
resolve, nor which infection would persist even af-
ter treatment with and evolve with the host tissue
division.
The implication of Chlamydia trachomatis with
mucopurulent cervicitis and plasma cell endome-
tritis was found of 64% of asymptomatic women in
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a recent work. 18 Sexually transmitted pathogens
like C. trachomatis and Neisseria gonorrhoeae play a
starter role in the infection by ascending the cervix,
followed by anaerobic and bacterial vaginosis-
associated bacteria. Pelvic inflammatory disease
and C. trachomatis are strongly associated. In a C.
trachomatis-PID model, 19 pro-inflammatory cyto-
kines were induced in the cervix 20 hours after
infection. Recurrent infections increase the risk for
PID, and prior PID increases the risk for infertil-
ity,z similar to the progressive scarring caused by
chronic trachoma. Susceptibility for PID is geneti-
cally restricted by the human leukocyte antigen
class-I antigens,z,zz A significantly higher preva-
lence of anti-C Hsp60 antibodies has been found in
patients with occluded tubes (90%) than in patients
from a sexually transmitted disease clinic infected
with C. trachomatis.9 C Hsp60 induces chronic T-
cell immunopathogenesis and produces autoim-
mune cross-reaction with human Hsp60 and im-
mune complex formation.
Two different situations appear clearly: the in-
vasion by the pathogen with acute inflammatory
host response and the persistent infection with a
chronic permanent inflammation and tissue dam-
age. What bears evidence is the presence of chla-
mydial antigens, Hsps, DNA, and RNA in diseased
tissue preparations, especially submucosae pro-
cessed with histologic techniques,s Those tissues
are usually culture negative, though, unless in
straining conditions where nutrients are carefully
added by multiple passages.6 We know that Hsps
are sufficient to activate T cells and promote TH1
cytokines. We also know that delayed hypersensi-
tivity and autoimmunity to human Hsp60 induce
lymphocyte and macrophage proliferation with
toxic products emission that concurs with fibrosis
and necrosis. Genital infection is not such a good
model of persistent infection as trachoma, in which
scarring and blindness can be observed. However,
as with trachoma, alteration of tissues leading to
functional impairment occurs after a previous in-
fection and without any sign other than the pres-
ence of nucleic acids, membrane antigens, and
stress proteins. Moreover, many works have long
associated tissue scarring with permanent inflam-
mation and delayed hypersensitivity due to auto-
immunity to self-Hsps,z3 Immunomodulation with
tumor necrosis factor-or (TNF-ot), Hsp60 or 70, and
major histocompatibility complex class-I genes
makes sense when their chromosomal proximity
is considered. Consistent with that assessment,
mRNA for TNF-ot and interleukins (IL) and 6
has been found in tubal tissues from patients with
ectopic pregnancy and tubal infertility.6,z This
finding proved that viable chlamydiae were there
and were associated with inflammation. Another
work even demonstrated that chlamydiae culti-
vated in macrophages from joint tissue of a Reiter
syndrome patient infected long ago became infec-
tious again. 7
Those works demonstrated the subclinical or
asymptomatic presence of chlamydiae in an incom-
plete, debilitated form capable of inducing inflam-
mation and thus necrosis and fibrosis under certain
conditions. From in vitro models, we could assume
that "persistent" chlamydiae could be responsible
for that particular physiopathology. But, they could
also be the inactive witnesses of the harm already
done by the active infection. However, the pres-
ence of mRNA in the tissues, and the power of
neoactivation into active infection, pledge for liv-
ing but quiescent material.
What do we learn from recent in vitro stud-
ies?8,zs Several factors inhibit the normal develop-
ment cycle of Chlamydia: host cell cytokines (inter-
feron-y with the mediation of TNF-ot), antibiotics
like penicillin, ampicillin, and chlortetracycline.
Cyclic nucleotides like cyclic adenosine mono-
phosphate (cAMP) and deprivation of nutrients
like tryptophan and cysteine impair the synthesis
of the elementary bodies (EBS) membrane outer
membrane proteins and thus the cell division and
differentiation of the reticulate bodies (RBS) that
remain large and atypical. To date such aberrant
RBS have not been identified in vivo, but condi-
tions of their presence could easily be reached in a
natural infection: cytokine emission from the host,
humoral anti-major outer membrane protein anti-
bodies with a partial protective effect to the host
cell, and deprived nutrient factors in deep tissues
with altered cell membrane functions. Antibiotics
like penicillin or ampicillin used for other infec-
tions can induce persistent forms. Tetracycline can
reverse the bactericidal effect if administered at
the wrong stage of the cycle. Moreover, those ad-
verse conditions induce a progressive disappear-
ance of the membrane proteins and an increase of
stress proteins which, as in other bacteria, contrib-
ute to the loss of susceptibility to antimicrobial
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agents. This observation is consistent with the
clinical inadequacy of classical treatments in
chronic infections. However, we do not know
whether this decreased susceptibility is due to the
antimicrobial itself or to the alterations of the mem-
brane.
CONCLUSION
Are silent genital chlamydial infections due to per-
sistent forms of Chlamydia? The nucleic acids,
Hsps, and antigens recognized in diseased tissues
that are culture negative for Chlamydia are suffi-
cient proof of immune stimulation and chronic ac-
tive disease. Persistent forms are admitted as stress
response forms capable of living again under favor-
able circumstances. Removal of factors inducing
persistence can reactivate resolved infections un-
der immunosuppressive conditions: coinfection
with N. gonorrhoeae or environmental factors like
hormones or vaginal flora. But, the consequence of
a blocked development cycle does not offer a pos-
sibility of chemotherapy for these infections. Per-
sistent abnormal forms must be recognized in vivo
before the clinical features of silent infections can
be assimilated to the cell-culture model of persis-
tent chlamydiae. Persistence, thus chronic disease,
might not occur after a well-treated uncomplicated
cervical infection. It is therefore important to rec-
ognize the risk for chronicity at the onset of an
infection. Anti- major outer membrane protein and
anti-lipopolysaccharidc antibodies could go unde-
tected in a chronic infection, so anti-C Hsp60 an-
tibodies should be routinely processed when a
chronic infection is suspected in cases of tubal in-
fertility or when in vitro fertilization fails. Treat-
ment of persistent silent diseases and resolution of
chronic infection should be improved by more
knowledge of persistent infection.
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